home / stock / obln / obln news

OBLN News and Press, Obalon Therapeutics From 12/18/19

Stock Information
Company Name: Obalon Therapeutics
Stock Symbol: OBLN
Market: NASDAQ
Menu
OBLN OBLN Quote OBLN Short OBLN News OBLN Articles OBLN Message Board
Get OBLN Alerts

News, Short Squeeze, Breakout and More Instantly...
OBLN - Obalon Enters into a Distribution Agreement for Qatar

SAN DIEGO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that it has e...
OBLN - Obalon To Present at Two Upcoming Institutional Investor Conferences

SAN DIEGO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a weight loss solutions company focused on commercializing the Obalon Balloon System, the first and only FDA-approved swallowable, gas-filled intra-gastric balloon for weight loss, anno...

OBLN - Obalon Therapeutics, Inc. (OBLN) Management on Q3 2019 Results - Earnings Call Transcript

Obalon Therapeutics, Inc. (OBLN) Q3 2019 Earnings Conference Call November 08, 2019 09:00 AM ET Company Participants Bill Plovanic - Chief Executive Officer Bob Macdonald - Chief Retail Officer Nooshin Hussainy - Chief Financial Officer Conference Call Participants Ben Hayn...

OBLN - DIS, GPRO among premarket gainers

Dermira (NASDAQ: DERM ) +29%  on apparent reaction to AnaptysBio's  etokimab flop  in a mid-stage atopic dermatitis study. More news on: Dermira, Inc., ObsEva SA, Sientra, Inc., Stocks on the move, Read more ...

OBLN - Obalon Therapeutics EPS of -$0.61

Obalon Therapeutics (NASDAQ: OBLN ): Q3 EPS of -$0.61 may not be comparable to consensus of -$5.70. More news on: Obalon Therapeutics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

OBLN - Obalon Announces Third Quarter 2019 Financial Results

SAN DIEGO, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for the thi...

OBLN - Obalon Announces Clinical Data Set to be Featured During the 36th ASMBS Annual Meeting at Obesity Week 2019

SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that clinical data for the Obalon B...
OBLN - Obalon Schedules Third Quarter 2019 Financial Results Conference Call for November 8, 2019 at 9:00 a.m. Eastern Time

SAN DIEGO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that it plans to release its third q...

OBLN - Obalon Appoints William J. Plovanic as Chief Executive Officer and Nooshin Hussainy as Chief Financial Officer

SAN DIEGO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a San Diego-based weight loss solutions company focused on commercializing the Obalon Balloon System, the first and only FDA-approved swallowable, gas-filled intra-gastric balloon for weight ...

OBLN - BIIB, CISN, HHC, SERV, STMP and TGP among notable midday movers

Gainers:  TrovaGene (NASDAQ: TROV ) +65% . Biogen (NASDAQ: BIIB ) +29% . Stamps.com (NASDAQ: STMP ) +24% . Teekay Corporation (NYSE: TK ) +22% . Cision (NYSE: CISN ) +19% . Teekay LNG Partners (NYSE: TGP ) +17% . Obalon Therapeutics (NASDAQ: OBLN ) +14%.  Athenex (NASDAQ: ...
Previous 10 Next 10